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ABSTRACT 
Interventional techniques using ultrasound guidance, such as Radio Frequency Ablation (RFA) of liver lesions, are 
the domain of the radiologist. However, real time ultrasound imaging as performed by the sonographer, is critical in 
monitoring the successful insertion and placement of the RFA needle. RFA is used to create a localised and controlled 
application of heat in order to induce necrosis of cells within the liver lesions.  
The role of the sonographer is to assist in establishing the criteria for RFA therapy. This includes assessing the liver 
to establish how easily the lesion can be identified; the size of the lesion; its proximity to large blood vessels and 
adjacent vital organs and the access route to the lesion itself. In essence, in this discussion, the focus will be on the 
sonographic techniques in the assessment of the liver prior to RFA and the RFA procedure itself. A brief review of the 
clinical role that can be provided by Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) is also 
included. © 2009 Biomedical Imaging and Intervention Journal. All rights reserved. 
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INTRODUCTION 
An extensive screening program is ideal to ascertain 
patients’ various aetiologies suspecting hepatic 
pathology or its progression. Suspicious lesions are 
followed up by triphasic Computed Tomography (CT) 
and a treatment plan organised based on the patient’s 
individual circumstance. 
Ultrasound is the ideal imaging modality to perform 
Radio Frequency Ablation (RFA) on liver lesions in 
patients for whom surgical resection is either not an 
option or not the preferred method of treatment. 
Ultrasound provides real time, non-ionising imaging to 
the clinician. Ultrasound is also suited for patients with 
breathing issues or back problems as the patient does not 
have to lie completely supine as with CT or Magnetic 
Resonance Imaging (MRI). CT can also be used in 
conjunction with ultrasound; or in a small number of 
cases such as advanced cirrhosis, CT may be the 
preferred modality.  
The focus of this article will be on the sonographer’s 
role in RFA therapy and the technique of RFA in treating 
liver lesions. 
Selection criteria for RFA 
The sonographer assumes an important role in 
ensuring the RFA selection criteria are adhered to. This 
section details the factors critical to the success of RFA 
liver therapy. 
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Patient Co-operation 
For those lesions which are not located peripherally 
in the liver, conscious sedation and analgesia are 
provided. In such instances, the patient’s ability to 
suspend respiration when required is of utmost 
importance. It is possible to perform this procedure under 
General Anaesthetic (GA) but the ultimate aim is to treat 
the lesion with minimally invasive techniques. 
Liver lesions located peripherally are best treated 
under GA with an anaesthetist present. RFA of these 
lesions is considered too painful both during and after the 
procedure and as such may affect patient’s ability to co-
operate. 
Sonographic Appearance 
Solid lesions of any description with a hypoechoic 
halo have always been regarded as suspicious and have a 
high association with malignancy. Most commonly these 
lesions are characteristic of metastases or Hepato 
Cellular Carcinomas (HCC’s). Although not an absolute 
indicator of tumour, lesions with a hypoechoic halo often 
require further investigation and or treatment of some 
type regardless of the patient’s health or symptoms. Due 
to the sonographic properties of some lesions which are 
highly vascularised, they are more likely to appear 
hyperechoic. Typically the tumours most often treated by 
RFA are echogenic foci within the liver. These are 
classic examples for colon metastases as well as 
neuroendocrine and vascular primaries. HCC’s are also 
echogenic [1]. These are generalised descriptions of liver 
lesions typical of HCC’s or Colo Rectal Carcinoma 
(CRC) metastases; however, these tumours can appear in 
any combination of the above or appear totally different 
to these typical descriptions.  
Nature of the Lesion 
Surgical resection of HCC’s detected in their early 
stage within a relatively healthy liver is the optimal 
choice. However if the patient is a non-surgical candidate, 
then RFA is the next most suitable therapy if the patient 
has normal bilirubin (both conjugated and unconjugated) 
and has no significant portal hypertension [2]. Liver 
lesions amenable to RFA treatment can be either primary 
hepatic lesions such as HCC’s or secondary metastases 
from CRC. However only those secondary liver 
metastases with no extrahepatic spread are considered for 
RFA. 
Location 
The location of liver lesions to be treated affects the 
success of the RFA procedure. Lesions that are too close 
to or invading the walls of major vessels within the liver, 
are unlikely to be treated successfully. This is because 
the moving blood draws the heat created by RFA away 
via convection and so it is not possible to ensure that the 
liver lesion has been coagulated by the heat effectively. 
Hence, liver lesions that are 3 cm or more in diameter 
which are abutting vessels will not be treated 
successfully [2]. 
Lesions located close to gastric or intestinal walls 
may endure heat related injury or even perforation if they 
are located within the ablation zone. If bowel injury is a 
possibility, an intraperitoneal injection of dextrose to 
displace bowel can be performed [2]. As the gastric wall 
is thicker than the intestinal wall, the gastric wall may be 
more resilient to heating necrosis during RFA treatment 
[2]. 
Proximity of the gall bladder within the necrosis 
zone is also undesirable as irritation of the gallbladder 
wall causes pain and possibly an iatrogenically induced 
cholecystitis. Those tumours located close to larger 
portal triads are also at risk of damaging the nearby bile 
ducts and causing the patient great pain [3]. 
Peripherally located liver lesions also require extra 
care and preparation. At this centre GA is recommended 
as the pain is too intense under standard sedation and 
analgesia. Lesions at the dome of the liver have the 
added complication of potential damage to the 
diaphragm. The use of an artificial pleural effusion for 
RFA of these lesions will help to avoid diaphragm 
damage [3]. 
Size and Number of Lesions  
Most radiologists will treat lesions in liver if: 
●  lesions number less than or no more than four; 
of which each is 5  cm or smaller, be they 
primary or secondary hepatic tumours with not 
extrahepatic masses [3].  
●  those patients with a background of liver 
cirrhosis are classified via the Child-Pugh class 
system. Only lesions in category A or B would 
be accepted for RFA [4]. 
If the target tumour is larger than the ablation 
periphery, overlapping regions must be performed in 
order to be sure that the entire tumour has been ablated 
[5]. 
A successful ablation should achieve 100
oC within 
tissue of a 2 cm to 5 cm radius around the needle tip and 
is held there between 8 minutes to 20 minutes per session 
[3]. Ablation is required not only for the entire lesion but 
also a 2  cm cuff of tumour free margin so that any 
microscopic tumour invasion at the periphery may also 
be eradicated. The edge of the ablative region can be 
observed sonographically by echogenic micro bubbles 
that occur when the tissue is heated by the radio 
frequency field [3]. 
Ideally, tumours should be at least 2 cm away from 
large portal or hepatic vessels to reduce cooling effects 
and be at least 1 cm away from liver capsule as this can 
affect adjacent anatomy and be extremely painful. For 
optimal results, a tumour should be 3 cm in radius or less 
[3]. This is because the lesion may require overlapping 
ablations unless it is less than 2 cm in diameter. 
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CONTRAINDICATIONS 
The following patients are contraindicated for RFA 
therapy 
●  Pacemakers (As patients become part of a 
closed loop electrical circuit, this may 
adversely affect pacemaker functioning) 
●  Close proximity to gallbladder 
●  Close proximity to major bile ducts 
●  Haemodynamically compromised patients 
●  Hip replacements (need to put grounding pads 
elsewhere) 
●  Child-Pugh Class C Cirrhosis 
●  Pregnancy [6] 
RFA MECHANISM 
Radio frequency (RF) generators operate at 460 kHz 
with a power setting of between 50 W to 200 W. Once 
the desired temperature is reached in target tissue, the 
power is automatically adjusted to a cool down setting as 
the Watts required to maintain the desired tissue 
necrotising temperature is reduced. The patient is part of 
a closed loop circuit including an: 
●  RF generation 
●  An electrode needle  
●  A large dispersive electrode (ground pads) 
An alternating current (AC) field in radiofrequency 
range is thus created within the patient. 
Due to the high resistance of tissue when compared 
with metal electrodes, those ions in target tissue which 
surround the electrode are highly agitated while they 
attempt to follow the direction of the alternating current 
[2]. This agitation causes frictional heat which acts to 
cause coagulative necrosis when local tissue temperature 
is between 50
oC to 100
oC. The difference between the 
small surface area of the needle electrode and the large 
area of the ground pads causes the generated heat to be 
focussed and concentrated around the needle electrode 
[2]. 
Heating the tissue around the needle tip above 
100
oC causes carbonisation or vaporisation of the tissue. 
The gas then provides insulation against the ablative 
field that the physician is attempting to establish. The 
needle tips are internally cooled to avoid tissue 
vaporisation. 
PATIENT PREPARATION  
Patients are given a suitable appointment time 
allowing for a procedural time of about 2-3 hours 
duration. The procedure is considered a day procedure 
and can proceed in one of two ways; 
1.  conscious sedation (ultrasound or CT machines 
required) 
2.  Full GA if lesion is located peripherally or if 
patient co-operation is in question, (equipment 
and anaesthetics team required). 
The procedure is usually scheduled as a morning 
procedure. This is so that the day unit can perform 4 hour 
post procedure observation and the patient can be 
discharged on the same day. The patient arrives at least 
2 hours before the procedure, to be admitted on time and 
have any blood product if required. A provisional 
overnight bed is usually considered should complications 
arise which may require surgical intervention.  
Regardless of which pain management technique is 
used, a full blood (including platelet count) work up is 
performed the week prior to the procedure. This will 
allow ample time to order fresh frozen platelets or other 
blood corrective products and ensure that the patient has 
ample time on the morning before the procedure to 
absorb them. 
If the patient has had external imaging performed to 
identify the lesion, those images are made available to 
the department in the week leading up to the appointment. 
This is so that the most appropriate preparation can be 
made. Body habitus may be a factor to determine if CT 
combined with ultrasound may be required (e.g. 
hypersthenic patients where the hepatic flexure of the 
bowel may make it difficult to see lesions even using an 
intercostal approach with only ultrasound). A cirrhotic 
liver may make it difficult for ultrasound to resolve 
posteriorly located lesions and so a combination of 
ultrasound with CT may be required. 
External imaging can be scanned into PACS 
(Picture Archiving and Communications System) and 
original images returned to the patient. This allows 
portability of imaging such that wherever the procedure 
takes place (ultrasound department with conscious 
sedation or CT with ultrasound machine combined, 
angiography or interventional room with ultrasound 
machine if full GA required) the images can be displayed 
at a moment’s notice, and the image manipulated as 
required (e.g. change zoom factor, brightness / contrast 
etc). 
DAY OF PROCEDURE  
On the day of the booked procedure, the 
sonographer liases with day unit nursing staff in the early 
morning. As sonographers, we ensure that full blood 
profile (namely International Normalised Ratio [INR], 
Partial Thromboplastin Time [PTT], Prothrombin Time 
[PT] and platelet count) are available and documented 
and to be within normal limits. Patients who have a 
background of liver disease may require platelets or 
other blood corrective factors before the procedure. To 
ensure the patient meets these criteria we discuss the 
patient’s preparation needs with nursing staff from day 
procedure unit. The preparation in addition to blood 
counts includes ensuring that the patient has a day bed, 
the patient has been fasting for 6  hours prior to the 
examination (we recommend nil orally from midnight 
the night before), the patient has been admitted and all 
paperwork is in order, the patient has been changed into 
a hospital gown and is lying on a trolley. We prefer the 
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patient on a trolley as the mattress is firmer (and so there 
is less of a concavity of the supine position, whereas the 
softer bed mattresses allow the middle of the patient to 
be in a slightly kyphotic position). Ease of portability of 
the trolley is another factor. Once the patient has had the 
RFA, the patient must remain in supine position for at 
least 4 hours to minimise any potential bleeding. 
If blood products are required for the patient, 
discussion with the patient’s primary nurse ensures that 
the product will have been administered and be effective 
by the time we send for the patient. If possible, the 
patient should be cannulated with a suitable line for 
analgesic drug therapy during the procedure. 
Once everything is ready we organise a porter to 
bring the patient on their trolley with their history and 
full drug chart. 
Once in our department, the patient is identified and 
the sonographer introduces themselves and the patient is 
reminded in brief of the procedure. We stress that the 
patient will be bed bound for the procedure and also for 
4  hours post procedure. If they need use of toilet 
facilities before we begin, it is offered. 
RFA PROCEDURE 
Ultrasound machines with the option of compound 
imaging are ideal to better delineate the lesion(s) within 
the liver. Harmonics may be useful if the lesion to be 
ablated is not deep; as tumours deep within the liver will 
not be observed due to the principles of harmonics. Most 
often, we use a curved 3 MHz to 5 MHz curved array 
transducer appropriately covered with a sterile cover 
using aseptic techniques. Standard gel is used for the 
initial scan but sterile gel is used on the sterile side of the 
cover during the procedure. In this facility we used either 
the Phillips IU22 or the ATL 5000. Sometimes due to the 
heterogenous or fatty nature of the liver to be treated, it 
was necessary to use the phased array 2 MHz to 5 MHz 
transducer. All factors are optimised, depth and focal 
zone set appropriately at or just deep to the area to be 
investigated. Standard power and contrast settings are 
used as per typical abdominal set up (1.1  Mechanical 
Index and approximately 60 decibels respectively). Gain 
is set adequately to observe the entire liver parenchyma 
with the Time Gain Compensation (TGC) at a mildly 
increasing curve toward the posterior edge of liver. 
After observation of previous imaging to identify 
target lesion, we scan the liver to ensure no further 
hepatic lesions or biliary pathology are present. The 
lesion is measured, the liver segment identified and 
colour Doppler is applied to the B mode image to check 
vascularity of tumour. In addition, the presence of any 
major hepatic or portal vessels in the immediate area are 
identified. If the patient has had recent prior ultrasound 
imaging in our department we will target our 
examination to the region of interest. If previous imaging 
is from an external source or prior imaging is more than 
a few weeks old, we will perform a full assessment of the 
liver and observe the gallbladder and bile ducts (figure 1). 
Also, as we are scanning we attempt to surmise the 
method of best approach of needle insertion. Ultimately 
the radiologist will determine the needle track. However, 
discussion with the patient may reveal information which 
will prove valuable in ensuring the success of the 
procedure. For instance, although a right posterior 
oblique position – with the patient lying on their left side 
– using an intercostal approach from lateral side may 
seem ideal; but if the patient has excruciating left hip 
pain and cannot lie still regardless of the level of 
 
Figure 1  Identification of liver segment and measurement of lesion (prior to RFA). 
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analgesic help, then a more anterior approach could be 
considered in order to obtain full patient co-operation.  
Such information gathered by the sonographer can 
streamline the preparation and allow the radiologist 
maximum time for ablation. Also while scanning, the 
patient is instructed on breathing technique and its 
importance to the success of the procedure. 
Nursing staff are then called in to assemble 
monitoring devices. A blood pressure cuff and oxygen 
saturation monitor are attached to the patient. On the 
opposite arm a needle is inserted (if not already done by 
day unit nurse) and checked with saline for patency. This 
line will remain insitu for the duration of the patient’s 
stay in the hospital for drug administration. 
Midazolam and fentanyl are the drugs of choice for 
sedation and analgesic unless contra-indicated. Oxygen 
is provided via nasal prongs or mask. The two grounding 
pads are placed on the patient’s thighs (shaved if 
necessary). Once an adequate baseline blood pressure 
and oxygen saturation (finger pulse oxymeter) have been 
established, the patient is ready to be formally consented 
in writing by the radiologist. Information gathered by the 
sonographer is discussed with the radiologist and then 
the RFA proceeds. The sonographer writes the report and 
awaits the end of the therapy to finalise the procedure. 
The radiologist also scans to conclude the best method of 
approach and practise breathing techniques with the 
patient.  
The skin is prepared after consent and the RFA 
machine positioned adequately. The grounding pads are 
also applied. 
The skin is cleansed with either chlorhexidine or 
iodine standard solutions using a sterile technique. 
Ultrasound transducers are covered with sterile covers 
and sterile gel is used. Using ultrasound guidance the 
RFA needle is advanced to the target lesion. A plunger at 
the proximal end of the 15 g needle is advanced [7] to 
deploy electrodes into the centre of the target lesion 
(figure 2). 
A multi-pronged umbrella of curved electrodes is 
lodged within the tumour and the generator is switched 
on. Different types of electrodes (available from a variety 
of manufacturers) can be used depending on the intended 
application, lesion size and lesion location. 
The temperature at the tips of the electrodes is 
controlled to achieve 100
oC for about 8  minutes to 
10 minutes. Once the target temperature is achieved, the 
system will reduce its output power. The electrodes can 
then be adjusted (e.g further deployed). The power 
required to maintain target temperature at the electrode 
tips is decreased (figures 3-6). 
Once the lesion has been ablated, the generator 
performs a cool down cycle [2]. The electrodes are then 
retracted and the needle track is also ablated using a 
lesser temperature of about 70-80
oC [2] to ensure no 
seeding of tumour occurs and to coagulate the track to 
reduce bleeding. Throughout the procedure, the patient’s 
vital signs are constantly monitored and recorded at 
various time intervals. 
Once the procedure has finished, the day unit nurse 
is contacted by the radiology nurse for handover to the 
day unit for observation. The patient is made as 
comfortable as possible. A suitable dressing is applied to 
the needle entry site on the skin and the equipment is 
cleaned and packed away. 
 
Figure 2  Needle tip (echogenic focus) in centre of lesion to be ablated. 
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Figure 3  Needle position confirmed immediately prior to ablation. 
 
 
 
 
 
 
 
Figure 4  Ablation in progress. Tumour and surrounding tissue are going through tissue necrosis and coagulation. 
As the tissue is undergoing severe heat conditions, the bleeding vessels are seared and microbubble 
formation appears as a hyperechoic cloud around the needle tip. 
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Figure 5  Microbubble formation as tissue necroses. As the ablation continues the microbubbles identify the 
periphery of the tissue necrosed. This should ideally be an extra 2cm cuff around the visible periphery 
of the original tumour. The first centimetre to treat non visible spread throughout liver tissue, the next 
centimetre to treat any microscopic growth outside the original perceived boundary. The hyperechoic 
cloud recedes and is replaced by a heterogenous, echogenic mass of tissue. 
 
 
 
 
 
 
Figure 6  On immediate completion of ablation. With time this lesion will appear less echogenic and shrink in size 
minimally. Follow up imaging with a triphasic CT or MRI is needed to ensure no tumour was left 
behind. 
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THE ROLE OF CT AND MRI IN RFA 
Ultrasound and CT are the two major imaging 
modalities used to assess liver lesions prior to RFA and 
CT has been the predominate tool used to assess post 
RFA treatment success and lesion follow-up [5,8-10].  
The real-time capabilities of ultrasound make it the 
most practical modality to incorporate electrode 
guidance and intra-procedure assessment [5]. However, 
both CT and MRI play a role in improving the candidate 
selection process for RFA and pre-procedure planning 
[4,11]; such as determining the most appropriate 
percutaneous pathway [12]. 
The added advantage of these imaging modalities is 
that they both provide the benefit of multi-planar 
imaging – CT via the software reformation process and 
MRI by direct imaging. Such multi-planar imaging helps 
to ascertain the appropriate percutaneous pathway. In 
addition, MRI has the added advantage of superior image 
contrast capabilities [13]. 
Traditionally and currently, post procedure follow-
up and assessment of tumour ablation success is 
commonly performed with contrast enhanced CT. 
However, there is an emerging trend to incorporate MRI 
into the post-procedure assessment of tumour response to 
RFA [13]. Some studies are demonstrating that with 
dedicated open architecture MRI systems, MRI can be 
used to improve RFA success intra-procedurally 
[14].The improved intra-procedure success rate and post-
procedure monitoring provided with MRI can be 
attributed to the understanding of the characteristic signal 
intensity demonstrated by liver tumours and also their 
contrast media enhancement characteristics. This has 
been confirmed with histological assessment in one 
particular study [13]. 
The MRI signal characteristics can be summarised 
as follows: 
●  On non-enhanced images, ablated necrotic 
tissue is demonstrated as a reduced signal 
pattern [13-17]. For example, when imaged 
with MRI, immediately following RF energy 
application, it is demonstrated as being hypo-
intense on a T2 weighted sequence. (CT 
demonstrates the same ablated necrotic tissue as 
hypo-dense and ultrasound will display it as 
hyper-echoic). A relatively hyper-intense rim of 
1 to 2 millimetres is also demonstrated. These 
imaging appearances are in relation to the 
normal healthy liver parenchyma. The reduced 
signal intensity is presumed to result from 
dehydration; that is, water molecules displaced 
to the periphery of ablation and coagulation 
zone. 
●  The zone of reduced signal as described above, 
should also appear as hypo-intense on a Short 
Tau Inversion Recovery (STIR) sequence [14].  
●  Following the administration of intravascular 
contrast media, a rim or ring enhancement 
pattern encompassing the ablated necrotic 
tissue is displayed on a T1 weighted sequence. 
The necrotic tissue itself should not 
demonstrate any signal enhancement. This 
should correspond to the hypo-intense zone 
demonstrated on the T2 weighted sequence 
[13-16]. 
●  Histologic assessment of the hyper-intense rim 
or ring reveals that it is comprised of 
haemmorhagic components, deteriorating 
hepatocytes and interstitial oedema [13,14]. 
This reflects the imaging characteristic of an 
increased signal. 
●  The dimensions of induced thermal coagulation, 
and therefore ultimately tumour necrosis, has 
been found to have a variable representation 
across a number of imaging sequences 
[13,14,16]. Non-enhanced T1 weighted images 
underestimate this by up to 5 millimetres. STIR 
images may overestimate this by up to 
3  millimetres. T2 weighted images may 
overestimate by up to 2  millimetres. Contrast 
enhanced T1 weighted images may 
overestimate this by up to 4 millimetres. 
Intra procedure MRI is not without its own inherent 
challenges [18]. It adds a further layer to the patient 
selection process as certain implanted devices are contra-
indicated to the MRI environment. Careful attention 
needs to be paid to the application and placement RF 
grounding pads and the RFA equipment may induce 
imaging artefacts which need to be minimised or 
overcome.  
Even though MRI guided ablation adds cost and 
increased overall procedure time, the benefits of MRI 
such as direct multi-planar imaging, superior contrast 
resolution, characteristic signal pattern, ability to better 
ascertain intra-procedure success, no ionising radiation 
and accurate post procedure assessment are the factors 
that render MRI as a very powerful modality to improve 
patient outcomes and medical management. 
SUMMARY 
A sonographer’s expertise is critical in ensuring the 
success of RFA procedure. However, the sonographer 
also assumes an important role in the overseeing of staff 
and equipment coordination with the aim of ensuring the 
best use of hospital resources. These responsibilities 
include the coordination of the patient preparation from 
booking, through to ensuring that blood analysis are 
performed and if necessary corrected on time, to patient 
arrival and ensuring the appropriate imaging are 
available.  
AN EXAMPLE CASE STUDY 
The following movie clips (movies 1-3) are taken 
from the same patient examination. This case is perhaps 
one of the more difficult types that may be encountered 
in the clinical setting. It is considered difficult for the 
following reasons: 
●  the size of the lesion to be ablated is very small; 
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Movie 1  Pre-RFA: Real-time ultrasound imaging is used to guide the RFA needle to the lesion. Please note the 
arrow pointing to the needle tip. It appears as a hyper-echoic focus deep within the liver. This is a 
transverse sector image of the fourth liver segment. 
 
 
 
Movie 2  RFA procedure in progress: This movie clip demonstrates the RFA process taking place. Note the 
hyper-echoic foci appearing around the needle tip, indicative of the ablation process. 
 
 
 
Movie 3  Post RFA: Take note of the hyper-echoic cloud in the region of the ablation. Ultrasound imaging is 
performed immediately post-RFA to determine that there is no bleeding and that the surrounding blood 
vessels have not been damaged. 
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●  this patient’s liver demonstrates ultrasound 
image characteristics of advanced cirrhosis, 
including a heterogeneous texture and irregular 
contour; and 
●  the patient has a large body habitus and the 
lesion under investigation is deep within the 
liver; and therefore a phased array transducer 
was used to optimise lesion detection. 
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